Home / Aduhelm (Drug) / Alzheimer's Disease / Drugs (Pharmaceuticals) / Inspectors General / F.D.A. Requests Federal Investigation of Alzheimer’s Drug Approval

F.D.A. Requests Federal Investigation of Alzheimer’s Drug Approval

The Guardian Express Saturday, July 10, 2021 Aduhelm (Drug), Alzheimer's Disease, Drugs (Pharmaceuticals), Inspectors General

https://ift.tt/3qZb1Uo

The agency’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules. By BY REBECCA ROBBINS from NYT https://ift.tt/3qZb1Uo

No comments

Subscribe to: Post Comments ( Atom )